1 / 8

Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

About Non-Hodgkin Lymphoma (NHL) and its Diagnostic Procedures Research Beam adds a report titled “Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018” that provides detailed information of the Non-Hodgkin Lymphoma Therapeutics.The report is an excellent piece of study for investors who are looking towards the market. Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances, the lymphocytes grow and die. However, in NHL they do not die; instead they grow and further divide. NHL can begin either in the T-cells or B-cells, though mostly it begins in the B-cells. The location of NHL is generally in the lymph nodes, but it can also spread to the body’s lymphatic system. It has many symptoms, of which swelling in the lymph nodes, abdominal pain, chest pain, cough, fever, fatigue, and night sweats are the most prominent. The causes of this disease are still unknown to scientists. NHL is linked with risk factors such as the overuse of immunosuppressant drugs, viruses such as HIV or Epstein-Barr, and bacteria such as Helicobacter pylori. NHL can be diagnosed by urine tests, physical examination for the enlargement of the lymph nodes, imaging tests (scans) such as magnetic resonance imaging (MRI) or computerized tomography (CT), and biopsy tests. TechNavio's analysts forecast the Global Non-Hodgkin Lymphoma Therapeutics market will grow at a CAGR of 7.03 percent over the period 2014-2018. Get Full Details On:http://www.researchbeam.com/global-non-hodgkin-lymphoma-therapeutics-2014-2018-market

Florence_2012
Télécharger la présentation

Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018 (Type, Mode of action, Crop Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeam.com Published on : Oct 2014

  2. Report Overview Research Beam adds a report titled “Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018” that provides detailed information of the Non-Hodgkin Lymphoma Therapeutics.The report is an excellent piece of study for investors who are looking towards the market. Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances, the lymphocytes grow and die. However, in NHL they do not die; instead they grow and further divide. NHL can begin either in the T-cells or B-cells, though mostly it begins in the B-cells. The location of NHL is generally in the lymph nodes, but it can also spread to the body’s lymphatic system. It has many symptoms, of which swelling in the lymph nodes, abdominal pain, chest pain, cough, fever, fatigue, and night sweats are the most prominent. The causes of this disease are still unknown to scientists. NHL is linked with risk factors such as the overuse of immunosuppressant drugs, viruses such as HIV or Epstein-Barr, and bacteria such as Helicobacter pylori. Get Full Details On: http://www.researchbeam.com/global-non-hodgkin-lymphoma-therapeutics-2014-2018-market

  3. Report Overview Covered in this Report This report covers the present scenario and the growth prospects of the Global Non-Hodgkin Lymphoma Therapeutics market for the period 2014-2018. The Global Non-Hodgkin Lymphoma Therapeutics market will observe a high growth in the forecast period. It is due to the availability of the biosimilars at a reduced price across the NHL market. This will be mainly due to the growth of the drug Rituxan in the global market. Apart from that, the market will also grow as a result of the improved diagnostic techniques to detect NHL. Besides, the increase in public awareness about NHL and robust drug pipeline for the treatment of NHL are the major influencers in the growth of the Global Non-Hodgkin Lymphoma Therapeutics market.Key Questions Answered in this Report • What will the market size be in 2018 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space?

  4. Table of Contents 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 03.1 Market Overview 03.2 Product Offerings 03.2.1 Product Profiles 04. Market Research Methodology 04.1 Market Research Process 04.2 Research Methodology 05. Introduction 06. Market Landscape 06.1 Market Overview 06.2 Market Size and Forecast 06.3 Five Forces Analysis 07. Rate of Incidence and Prevalence

  5. Table of Contents 08. Market Segmentation by Type of Therapy 09. Pipeline Portfolio 10. Geographical Segmentation 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 19. Key Vendor Analysis

  6. List of Exhibits Exhibit 1: Market Research Methodology Exhibit 2: Global Non-Hodgkin Lymphoma therapeutics market (in US$ billions) Exhibit 3: Global Non-Hodgkin Lymphoma Therapeutics Market by Type of Therapy Exhibit 4: Pipeline Portfolio of Global Non-Hodgkin Lymphoma Therapeutics Market Exhibit 5: Global NHL Therapeutics Market by Geographical Segmentation 2013 Exhibit 6: Bristol-Myers Squibb Co.: Product Segmentation (Based on Therapeutic Areas) Exhibit 7: Bristol-Myers Squibb Co.: Sales by Geography 2013 Exhibit 8: Celgene Corp.: Business Segmentation by Revenue 2011-2013 (US$ million) Exhibit 9: Celgene Corp.: Sales by Geography 2013 Exhibit 10: Eli Lilly and Co.: Business Segmentation by Revenue 2013 Exhibit 11: Eli Lilly and Co.: Business Segmentation by Revenue 2012 and 2013 (US$ million) Enquiry About Report: http://www.researchbeam.com/global-non-hodgkin-lymphoma-therapeutics-2014-2018-market/enquire-about-report

  7. Similar Market Studies Published Reports Vegetable Factories Market in Japan 2014-2018 http://www.researchbeam.com/vegetable-factories-in-japan-2014-2018-market Insulin Market in China 2014-2018 http://www.researchbeam.com/insulin-in-china-2014-2018-market Global Synthetic and Bio-based Biodegradable Plastics Market 2014-2018 http://www.researchbeam.com/global-synthetic-and-bio-based-biodegradable-plastics-2014-2018-market

  8. FOR MORE DETAILS Visit us at : http://www.researchbeam.com Stay With Us: 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeam.com

More Related